Sodium Channel (Dys)Function and Cardiac Arrhythmias

被引:111
作者
Remme, Carol Ann [1 ]
Bezzina, Connie R. [1 ]
机构
[1] Univ Amsterdam, Acad Med Ctr, Dept Expt Cardiol, Heart Failure Res Ctr, NL-1100 DE Amsterdam, Netherlands
关键词
Arrhythmias; Brugada syndrome; Long QT3; SCN5A; Sodium channels; LONG-QT SYNDROME; ACUTE MYOCARDIAL-INFARCTION; SICK SINUS SYNDROME; BRUGADA-SYNDROME; HEART-FAILURE; DILATED CARDIOMYOPATHY; NA+ CHANNEL; VENTRICULAR-ARRHYTHMIAS; MOLECULAR-MECHANISM; CONDUCTION DISEASE;
D O I
10.1111/j.1755-5922.2010.00210.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
P>Cardiac voltage-gated sodium channels are transmembrane proteins located in the cell membrane of cardiomyocytes. Influx of sodium ions through these ion channels is responsible for the initial fast upstroke of the cardiac action potential. This inward sodium current thus triggers the initiation and propagation of action potentials throughout the myocardium and consequently plays a central role in excitability of myocardial cells and proper conduction of the electrical impulse within the heart. The importance of sodium channels for normal cardiac electrical activity is emphasized by the occurrence of potentially lethal arrhythmias in the setting of inherited and acquired sodium channel disease. During common pathological conditions such as myocardial ischemia and heart failure, altered sodium channel function causes conduction disturbances and ventricular arrhythmias. In addition, sodium channel dysfunction caused by mutations in the SCN5A gene, encoding the major sodium channel in heart, is associated with a number of arrhythmia syndromes. Here, we provide an overview of the structure and function of the cardiac sodium channel, the clinical and biophysical characteristics of inherited and acquired sodium channel dysfunction, and the (limited) therapeutic options for the treatment of cardiac sodium channel disease.
引用
收藏
页码:287 / 294
页数:8
相关论文
共 93 条
  • [1] Regulation of the voltage-gated cardiac sodium channel Nav1.5 by interacting proteins
    Abriel, H
    Kass, RS
    [J]. TRENDS IN CARDIOVASCULAR MEDICINE, 2005, 15 (01) : 35 - 40
  • [2] Quinidine induced electrocardiographic normalization in two patients with Brugada syndrome
    Alings, M
    Dekker, L
    Sadée, A
    Wilde, A
    [J]. PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 2001, 24 (09): : 1420 - 1422
  • [3] Fever increases the risk for cardiac arrest in the Brugada syndrome
    Amin, Ahmad S.
    Meregalli, Paola G.
    Bardai, Abdennasser
    Wilde, Arthur A. M.
    Tan, Hanno L.
    [J]. ANNALS OF INTERNAL MEDICINE, 2008, 149 (03) : 216 - 218
  • [4] Novel Brugada syndrome-causing mutation in ion-conducting pore of cardiac Na+ channel does not affect ion selectivity properties
    Amin, AS
    Verkerk, AO
    Bhuiyan, ZA
    Wilde, AAM
    Tan, HL
    [J]. ACTA PHYSIOLOGICA SCANDINAVICA, 2005, 185 (04): : 291 - 301
  • [5] [Anonymous], 1989, NEW ENGL J MED, V321, P406
  • [6] Brugada syndrome - Report of the second consensus conference
    Antzelevitch, C
    Brugada, P
    Borggrefe, M
    Brugada, J
    Brugada, R
    Corrado, D
    Gussak, I
    LeMarec, H
    Nademanee, K
    Riera, ARP
    Shimizu, W
    Schulze-Bahr, E
    Tan, H
    Wilde, A
    [J]. HEART RHYTHM, 2005, 2 (04) : 429 - 440
  • [7] Electrophysiological effects of ranolazine, a novel antianginal agent with antiarrhythmic properties
    Antzelevitch, C
    Belardinelli, L
    Zygmunt, AC
    Burashnikov, A
    Di Diego, JM
    Fish, JM
    Cordeiro, JM
    Thomas, G
    [J]. CIRCULATION, 2004, 110 (08) : 904 - 910
  • [8] Antzelevitch C, 2006, HANDB EXP PHARMACOL, V171, P305
  • [9] Brugada syndrome
    Antzelevitch, Charles
    [J]. PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 2006, 29 (10): : 1130 - 1159
  • [10] Atrial-selective sodium channel block as a novel strategy for the management of atrial fibrillation
    Antzelevitch, Charles
    Burashnikov, Alexander
    [J]. JOURNAL OF ELECTROCARDIOLOGY, 2009, 42 (06) : 543 - 548